Carcinoembryonic antigen (CEA) is normally found in embryonic entodermal epithelium. Carcinoembryonic antigen is a group of glycoprotein present in the body fluids of the fetus and embryo and in the gastrointestinal tract. Carcinoembryonic antigen is also present in the mucosal cells of the colorectum, gastrointestinal cells, and small amounts are present in the blood.
Carcinoembryonic antigen is produced by the gastrointestinal tissues during the development of fetal. CEA is not present in the healthy adults but cancer patients show concentrations of CEA. A carcinoembryonic antigen test is generally a blood test that measures the amount of carcinoembryonic antigen protein in the blood.
The test is also used to manage and diagnose certain types of cancers like breast cancer, colorectal or colon cancer, cancer of the gastrointestinal tract, liver cancer, ovarian cancer, lung cancer and others. The sensitivity of carcinoembryonic antigen is low for early colon cancer patients.
The Carcinoembryonic antigen (CEA) test is especially used for cancers of the rectum and large intestine. Carcinoembryonic antigen is one of the most commonly used tumor markers globally. But its primary significance is in colorectal cancer.
According to WHO, Cancer is the second leading cause of death globally and accounted for 8.8 million death in 2015. Globally, nearly 1 in 6 deaths is due to cancer. Around one third of deaths from cancer are due to the 5 leading behavioral and dietary risks: high body mass index, low fruit and vegetable intake, lack of physical activity, tobacco use, and alcohol use.
Global carcinoembryonic antigen (CEA) market is expected to grow over the forecast period due to the factors such as rising prevalence of cancer, high demand for minimally invasive diagnostic procedures in cancer and increasing per capita healthcare expenditure. Rapidly increasing geriatric population who are prone to chronic medical conditions including cancer is likely to drive the market growth.
In addition, the introduction and constant development of the novel immunological techniques like the radioimmunoassay is expected to increase the demand for carcinoembryonic antigen tests. However, the risk of infections by CEA testing will restrain the market growth of the global carcinoembryonic antigen during the projected period.
The global carcinoembryonic antigen (CEA) market is classified on the basis of application type, end user, and geography.
Based on application type, the global carcinoembryonic antigen (CEA) Market is segmented into the following:
Based on end user, the global carcinoembryonic antigen (CEA) market is segmented into the following:
Based on the application type, the global carcinoembryonic antigen (CEA) Market is segmented into colorectal cancer, pancreatic cancer, breast cancer, lung cancer, ovarian cancer and others. Carcinoembryonic antigen (CEA) application in colorectal cancer dominated the overall market. Increasing consumption of alcohol increases the growth of colorectal cancer.
Breast cancer is expected to be the fastest growing application segment due to the rising demand for Hormone Replacement Therapy (HRT), increasing number of female population above 50 years and cosmetic surgeries. Based on end user, the global carcinoembryonic antigen market is segmented into hospitals, diagnostic centers, cancer centers and research centers.
Region wise, the global carcinoembryonic antigen (CEA) market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, and Middle East and Africa.
North America expected to dominate the global market for carcinoembryonic antigen (CEA) market due to the high incidence rates of cancer, presence of sophisticated healthcare infrastructure, and high patient awareness levels in the region. The presence of available opportunities and constantly improving healthcare infrastructure is expected to boost the growth of the carcinoembryonic antigen market growth in APEJ region over the forecast period.
Key players operating in the global carcinoembryonic antigen market include F. Hoffmann-La Roche Ltd, Abbott Diagnostics, Quest Diagnostics, Lee Biosolutions, Inc., and RayBiotech, Inc. Manufacturers face difficult price-based competition and are also under endless pressure to introduce technologically new advanced products.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
Antigen Skin Test Market Growth – Trends & Forecast 2025 to 2035
Rapid Antigen Testing Market - Demand, Growth & Forecast 2025 to 2035
Cancer Antigens Market
Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Analysis and Forecast by Type, Application, End User, and Region Through 2035
The Cryptococcal Antigen Lateral Flow Assay Test Market is segmented by Lateral Flow Readers and Kits and Reagents from 2025 to 2035
Mycoplasma Plate Antigens Market Size and Share Forecast Outlook 2025 to 2035
Prostate-Specific Antigen Testing Market Analysis - Size, Share & Forecast 2025 to 2035
Rosacea-Targeting Skincare Market Analysis - Size and Share Forecast Outlook 2025 to 2035
Oceania Digital Textile Printer Market Size and Share Forecast Outlook 2025 to 2035
Food Traceability Market Size and Share Forecast Outlook 2025 to 2035
Recycled Ocean Plastic Packaging Market Size and Share Forecast Outlook 2025 to 2035
Ponceau 4R Colors Market Size and Share Forecast Outlook 2025 to 2035
Ocean Freight Forwarding Market Size and Share Forecast Outlook 2025 to 2035
Oceania Commercial Ice Machine Market Insights – Growth & Demand Forecast 2025 to 2035
Concealed Weapon Detection Systems Market Trends – Growth & Forecast 2025-2035
Compliance and Traceability Solution Market – AI-Powered Regulations
Controlled Environment Agriculture (CEA) Market Size and Share Forecast Outlook 2025 to 2035
Carcinoembryonic Antigen (CEA) Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
Chat With
MaRIA
